CVS HEALTH Corp Earnings Summary — Q1 2026

• Revenue surpassed $100 billion in a single quarter for the first time, reflecting massive scale.
• Net income saw a significant 65% year-over-year increase compared to Q1 2025.
• Operating income rose to $4.68 billion, nearly doubling the prior quarter's performance.
• The integrated model continues to drive scale, now representing roughly 10% of total US healthcare spend.
• Year-over-year revenue growth remained steady at 6.17%, though slightly trailing the 8.17% growth seen in Q4 2025.
• The company successfully recovered from a volatile 2025 where it faced significant quarterly earnings swings.
• Diluted shares outstanding increased slightly to 1,279 million, up from 1,264 million a year prior.

Management remains focused on proving the synergy value of the pharmacy, PBM, and insurance segments following activist investor scrutiny. Efforts are concentrated on integrating primary care assets like Oak Street Health and Signify Health despite headwinds in Medicare Advantage medical loss ratios.

Improving

After a highly volatile 2025 characterized by earnings misses and guidance revisions, Q1 2026 shows a strong stabilization in both operating income and net profit margins.

The company faces a challenging environment in its Health Care Benefits segment due to regulatory changes in Star Ratings and rising medical cost trends, but its diversified revenue streams from Caremark and Retail Pharmacy provide a defensive buffer.